Literature DB >> 23255342

Hemodynamic variations due to spiral blood flow through four patient-specific bifurcated stent graft configurations for the treatment of abdominal aortic aneurysms.

Florian Stefanov1, Tim McGloughlin, Patrick Delassus, Liam Morris.   

Abstract

Endovascular repair is now a recognised procedure for treating abdominal aortic aneurysms. However, post-operative complications such as stent graft migration and thrombus may still occur. To assess these complications numerically, the correct input boundary conditions, which include the full human aorta with associated branching, should be included. Four patient-specific computed tomography scanned bifurcated stent grafts (SGs) were modelled and attached onto a full human aorta, which included the ascending, aortic arch and descending aortas. Two of the SG geometries had a twisted leg configuration, while the other two had conventional nontwisted leg configurations. Computational fluid dynamics was completed for both geometries and the hemodynamics assessed. The complexity of the flow patterns and secondary flows were influenced by the inclusion of the full human aorta at the SG proximal section. During the decelerating phase significant recirculations occurred along the main body of all SG configurations. The inclusion of the full human aorta did not impact the velocity contours within the distal legs and there was no difference in drag forces with the SG containing the full human aorta and those without. A twisted leg configuration further promoted a spiral flow formation along its distal legs.
Copyright © 2012 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Year:  2012        PMID: 23255342     DOI: 10.1002/cnm.2525

Source DB:  PubMed          Journal:  Int J Numer Method Biomed Eng        ISSN: 2040-7939            Impact factor:   2.747


  1 in total

1.  Efficiently Simulating an Endograft Deployment: A Methodology for Detailed CFD Analyses.

Authors:  Faidon Kyriakou; Craig Maclean; William Dempster; David Nash
Journal:  Ann Biomed Eng       Date:  2020-05-11       Impact factor: 3.934

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.